Most innovative medicine concept stocks are experiencing a pullback, with Sile Medical hitting the limit down.

Most concept stocks of innovative drugs have experienced a pullback, with Zai Lili Medical hitting the limit down, Asia Pacific Pharmaceuticals falling by over 9%, and Shuanglu Pharmaceuticals, Xin Hua Pharmaceuticals, and Kanzhi Pharmaceuticals leading the decline.